REQUEST A DEMO
Total
USD $0.00
Search more companies

CH Biotech R&D Co., Ltd. (Taiwan, China)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Full name: CH Biotech R&D Co., Ltd. Profile Updated: March 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

CH Biotech R&D Co., Ltd. specializes in the development of agricultural biotechnology products such as: fertilizer and chemical source materials. The company was established on November 29, 2013 and located in Nantou County.

Headquarters
No.89, Wenxian Rd
Nantou County; Nantou County;

Contact Details: Purchase the CH Biotech R&D Co., Ltd. report to view the information.

Website: http://www.chbio.com

Basic Information
Total Employees:
Purchase the CH Biotech R&D Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the CH Biotech R&D Co., Ltd. report to view the information.
Financial Auditors:
Purchase the CH Biotech R&D Co., Ltd. report to view the information.
Incorporation Date:
November 29, 2013
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
23.81%
Purchase this report to view the information.
18.78%
Purchase this report to view the information.
0.33%
Purchase this report to view the information.
0.16%
Purchase this report to view the information.
0.1%
Subsidiaries
Ch Biotech Llc. (United States)
100%
Company Performance
Financial values in the chart are available after CH Biotech R&D Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
5.63%
Total operating revenue
5.94%
Operating profit (EBIT)
11.8%
EBITDA
1.92%
Net Profit (Loss) for the Period
-0.46%
Total assets
14.21%
Total equity
20.72%
Operating Profit Margin (ROS)
2.08%
Net Profit Margin
-1.87%
Return on Equity (ROE)
-3.91%
Debt to Equity Ratio
9.32%
Quick Ratio
-0.07%
Cash Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?